N-SIDEannounced that AstraZeneca has signed an agreement to implement the N-SIDE solutions. Within the scope of this agreement , AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain.
John Murray, Supply Chain Transformation Lead, AstraZeneca
Thanks to the N-SIDE solutions, AstraZeneca will achieve a centralization of their clinical supply chain management. The N-SIDE solution will support both strategic decision-making during protocol design as well as operational planning and change management of on-going trials. The business intelligence dashboards will be used for real-time trial monitoring, results visualization and supporting cross-department communication.
“We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE solutions to manage their clinical supply chain”
Jacques Parlongue, N-SIDE CEO
N-SIDE has provided consulting services for AstraZeneca clinical trial supply optimization since 2017.
The N-SIDE offers a cutting edge, cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE solutions are based on advanced analytics, including optimization and machine learning, to support strategic and operational decision-making as well as facilitate trial monitoring with real-time data and knowledge sharing.
The N-SIDE Production App gives you unprecedented flexibility to optimize manufacturing for your clinical projects.
Use the Production App to build and maintain an optimal clinical production plan that accounts for your specific constraints. Then use advanced analytics to model any what-if scenario,to respond quickly and efficiently to unexpected changes.
The N-SIDE Supply App is the only solution that adds a risk-based optimization approach to clinical supply forecasting.
Make data-driven decisions about overage, packaging, sourcing, IRT setup, depot shipments, and more, all while measuring the precise impact of these decisions on patient service level and budgets.